EXTRACORPOREAL HEART AND LUNG TREATMENTS
We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]
We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.[1]
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. As human organs are a mutually linked system, Fresenius Medical Care pursues a multi-organ support approach in Critical Care, drawing on its extensive expertise in extracorporeal blood treatment for acute kidney injury.
We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people.
For patients. Worldwide. Every day.
BY
YOUR
SIDE
GET IN TOUCH WITH US!
Find the right person for your topic with our contact form.
Heart & Lung Campus
Join, Learn, Care
Looking for further treatment and product information?
Join our Heart & Lung Campus to explore various e-learning modules, for example expert interviews, best-practice-cases, medical information, hands-on-tutorials and priming instructions.
On demand, 24 hours a day, 7 days a week – whenever you need it.
News
News
35th Symposium Intensivmedizin + Intensivpflege
Thanks a lot for visiting our booth and symposium at the 35th Symposium Intensivmedizin + Intensivpflege in Bremen. We shared new insights, and it was great to see you.
News
SWAAC ELSO 2025 Conference
Thanks for a great SWAAC ELSO 2025 Conference! We shared new insights, had great conversations and enjoyed spending time in Abu Dhabi. See you next year!
EACTS Annual Meeting 2024
Thank You, EACTS Annual Meeting 2024! Grateful to the organizers, speakers, and everyone who made this event a success. It was an inspiring time of innovation, insights, and great connections. Looking forward to applying what we’ve learned and staying in touch!
Events
18. – 21. March
ISICEM 2025
44th International Symposium on Intensive Care and Emergency Medicine
Visit our booth and find out more about Xenios 2.0!
https://www.isicem.org/1/Home.asp
Venue
Brussels Meeting Center, BelgiumMont des Arts
Brussels, 1000 Belgium
23. – 26. April
EuroELSO Congress 2025
13th EuroELSO (European Extracorporeal Life Support Organization) Congress
Join our breakfast symposium and visit our booth!
https://euroelso-congress.com/
Venue
Milano Congressi, Italy
27. – 30. April
ISHLT 2025
45th Annual Meeting & Scientific Sessions of the ISHLT (International Society for Heart and Lung Transplantation)
https://www.ishlt.org/annual-meeting
Venue
John B. Hynes Veterans Memorial Convention Center Boston, MA USA
07. – 10. May
EPNV 2025
17th European Conference on Pediatric and Neonatal Mechanical Ventilation
Visit our booth!
Venue
Kursaal Interlaken, Switzerland
[1] ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1.4 August 2017, Ann Arbor, MI, USA
[2] Peek, G. et al. (2009). Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 374(9698), 1351–1363
[3] Combes, A. et al. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med, 378(21), 1965–1975